TCGA Study Provides 'Roadmap' for Targeted Therapy, Genomic Subtyping in Ovarian Cancer
June 29, 2011
TCGA Study Provides 'Roadmap' for Targeted Therapy, Genomic Subtyping in Ovarian Cancer
The team performed whole-exome sequencing, mRNA and microRNA expression profiling, methylation analysis, pathway analysis, and genotyping of more than 300 tumor samples, identifying potential treatment strategies and subtypes, and also providing a comprehensive picture of high-grade serous ovarian cancer tumor.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- CHOP's Joint Genome Center Turns to Sequencing for MDx and Drug Repositioning
March 14, 2012 / Clinical Sequencing News - Exome Sequencing IDs Druggable BRAF Mutation in 47 HCL Patients
June 15, 2011 / Clinical Sequencing News - Researchers Report on Mutational Patterns in Adenoid Cystic Carcinoma
May 20, 2013 / GenomeWeb Daily News - Clinical Next-Gen Sequencing Will Usher in Changes for Vendors, Execs Say at Burrill Conference
October 5, 2011 / GenomeWeb Daily News - Swedish Project Will Sequence Tumor Exomes to Study Drug Resistance, Develop Companion Tests
August 31, 2011 / Clinical Sequencing News